Evaluation of Three VAMPtide^® Substrates for Botulinum Neurotoxin Type B
Nancy Shine and Tanja Ouimet – presented at the 49th Annual Interagency Botulinum Research Coordinating Committee Meeting, September 2012 in Baltimore Maryland

Sensitive and Specific Bifunctional Assay for Botulinum Neurotoxin Type A
Kayana Suryadi, Todd Christian, and Nancy Shine – presented at the 49th Annual Interagency Botulinum Research Coordinating Committee Meeting, September 2012 in Baltimore Maryland

Sensitive Detection of Botulinum Neurotoxin Type A Using High Affinity Polyclonal Antibodies
Kayana Suryadi, Todd Christian, and Nancy Shine – presented at the 7th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, October 2011 Santa Fe, NM.

New FRET Substrate For Botulinum Neurotoxin Type A
Nancy Shine and Kayana Suryadi - presented at the 7th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, October 2011 Santa Fe, NM.

New SV2c Construct for Use in Binding and Detecting Botulinum Neurotoxin Type A
Todd Christian, Kayana Suryadi, and Nancy Shine - presented at the 7th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, October 2011 Santa Fe, NM.

Ultra Sensitive HPLC Detection Assay for Botulinum Neurotoxin Type A
Todd Christian, Kayana Suryadi and Nancy Shine - presented at the 47th Annual Interagency Botulinum Research Coordinating Committee Meeting, November 2010 in Atlanta, GA

Evaluation of a Small Peptide Inhibitor and A Control Peptide for Botulinum Neurotoxin, Type A
Nancy Shine, Kayana Suryadi and Todd Christian - presented at the 47th Annual Interagency Botulinum Research Coordinating Committee Meeting, November 2010 in Atlanta, GA

FRET Peptide Substrates for BotulinumNeurotoxins Types A, B, C, and E
Elena Endrukaite, Todd Christian, and Nancy Shine - presented at the 46th Annual Interagency Botulinum Research Coordinating Committee Meeting, October 2009 in Alexandria, VA.

Sensitive, In Vitro, Bifunctional, Potency Assay For Botulinum Neurotoxin Type A
Todd Christian and Nancy Shine - presented at the 46th Annual Interagency Botulinum Research Coordinating Committee Meeting, October 2009 in Alexandria, VA.

Ultra Sensitive HPLC Detection Assay for Botulinum Neurotoxin Type A SYNTAXtide,
FRET Substrate for Botulinum Toxin Type C
T. Christian, E. Endrukaite, and N. Shine - presented at the 7th Annual ASM Biodefense and Emerging Diseases Research Meeting, February 2009 in Baltimore, MD.

Functional Assay for Botulinum Neurotoxin Type A Utilizing the Neuronal Receptor Protein SV2c.
Todd Christian, Andreas Rummel, and Nancy Shine - presented at the 45th Annual Interagency Botulinum Research Coordinating Committee Meeting, September 2008 in Philadelphia, PA.

Capture Assay for Botulinum Neurotoxin Type A Utilizing the Neuronal Receptor Protein SV2c.
Todd Christian and Nancy Shine - presented at the 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, June 2008 in Baveno, Italy.

New High Affinity Antibodies Against Botulinum Neurotoxin Type A.
Todd Christian, Nancy Shine, and Karen Crawford - presented at the 6th Annual ASM Biodefense and Emerging Diseases Research Meeting, February 2008 in Baltimore, MD.

FRET Peptide Substrates for the Botulinum Toxins Type A, B, and E and for Anthrax Lethal Factor.
Todd Christian, Nancy Shine, and Karen Crawford - presented at the 5th Annual ASM Biodefense and Emerging Diseases Research Meeting, February 2007 in Washington, D.C.

SNAP Etide, a FRET Substrate for Botulinum Toxin Type E.
Yuliya Primak, Todd Christian, and Nancy Shine presented at the 43nd Annual IBRCC, November 2006 in Silver Springs, Maryland.

Sensitive and Specific Assay to Measure Endoprotease Activity of Botulinum Toxin Type A Holotoxin in Milk.
Nancy Shine, Linda Eaton, and Karen Crawford presented at the 42nd Annual IBRCC, December 5-8, 2005 in Baltimore, Maryland.

Physical Characteristics of rLF and rPA: Effects on Enzymatic Activity and Binding.
Nancy Shine, Cindy Le, Linda Eaton, and Karen Crawford presented at Bacillus Act 2005, September 25-29, 2005 in Sante Fe, New Mexico.

Comparison of Activity of Botulinum Neurotoxin Type A Holotoxin and Light Chain Using SNAPtide^® FRET Substrates.
T. Christian, N. Shine, L. Eaton, K. Crawford - presented at the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, June 2005 in Denver, Colorado, USA.

Rapid, Sensitive and Specific Assay to Measure the Endoprotease Activity of Botulinum Toxin Type A.
N. Shine, T. Christian, L. Eaton, K. Crawford - presented at the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, June 2005 in Denver, Colorado, USA.

Internally Quenched Fluorogenic Substrates for Anthrax Lethal Factor.
N. Shine, L. Eaton, K. Crawford - presented at the 5th International Conference on Anthrax, March 30, 2003 in Nice, France.